Market closedNon-fractional

Ultragenyx Pharmaceutical/RARE

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Ultragenyx Pharmaceutical

Ticker

RARE

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Novato, United States

Employees

1,276

RARE Metrics

BasicAdvanced
$3.7B
Market cap
-
P/E ratio
-$7.96
EPS
0.60
Beta
-
Dividend rate
$3.7B
0.6
2.427
2.087
625.038
664.585
-8.77%
-26.97%
-340.05%
7.13
24.11
-48.89
-5.8
15.29%
-22.34%
9.82%
35.14%

What the Analysts think about RARE

Analyst Ratings

Majority rating from 21 analysts.
Buy

RARE Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-156.80% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$109M
-14.53%
Net income
-$171M
38.59%
Profit margin
-156.80%
62.15%

RARE Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 17.24%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$2.25
-$2.23
-$1.52
-$2.03
-
Expected
-$2.07
-$2.08
-$1.62
-$1.73
-$1.71
Surprise
8.47%
7.31%
-6.15%
17.24%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Ultragenyx Pharmaceutical stock?

Ultragenyx Pharmaceutical (RARE) has a market cap of $3.7B as of July 04, 2024.

What is the P/E ratio for Ultragenyx Pharmaceutical stock?

The price to earnings (P/E) ratio for Ultragenyx Pharmaceutical (RARE) stock is 0 as of July 04, 2024.

Does Ultragenyx Pharmaceutical stock pay dividends?

No, Ultragenyx Pharmaceutical (RARE) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next Ultragenyx Pharmaceutical dividend payment date?

Ultragenyx Pharmaceutical (RARE) stock does not pay dividends to its shareholders.

What is the beta indicator for Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical (RARE) has a beta rating of 0.6. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Ultragenyx Pharmaceutical stock

Buy or sell Ultragenyx Pharmaceutical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing